Biomimetic Electrospinning Technologies
BET develops biomimetic scaffolds for research, and wound healing as well as producing tissue engineered substitutes for diseased tissues.
- Stage Concept Only
- Industry Biotechnology
- Location Seattle, WA, USA
- Currency USD
- Founded October 2011
- Employees 1
- Website biomimeticespintech.com
Company Summary
BET uses a novel electrospinning technique to produce fibroporous scaffolds that mimic native tissues. These scaffolds are used for research, wound healing, and tissue engineering (TE). The limitation in existing TE is that the engineered tissues don't perform like native tissue. Our technology doesn’t have this limitation thus providing a differential advantage for researchers, clinicians, and health care institutes that use our products.
Team
-
Stuart Brian MitchellPresident
Dr. Mitchell is the founder of BET. He developed the technology for making tissue engineering scaffolds that mimic native tissue structural architectures and mechanical properties. Dr Mitchell is a biomedical scientist who specializes in tissue engineering, biomechanics, biomedical instrumentation and control systems. He has been involved in biomedical engineering for 19 years prior to which his experience was in small business management.
Advisors
-
Legal ZoomLawyerUnconfirmedTom McfersonAccountantUnconfirmed
Previous Investors
-
Stuart B Mitchell, PhDUnconfirmedJean M Maixner, DVMUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.